UBS’s Rockwell Medical RMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$461K Buy
458
+8
+2% +$9.04K ﹤0.01% 4360
2014
Q2
$594K Sell
450
-213
-32% -$256K ﹤0.01% 4049
2014
Q1
$923K Sell
663
-138
-17% -$179K ﹤0.01% 3565
2013
Q4
$920K Buy
801
+175
+28% +$241K ﹤0.01% 3635
2013
Q3
$786K Buy
626
+391
+166% +$265K ﹤0.01% 3619
2013
Q2
$93K Buy
+235
New +$99.6K ﹤0.01% 6000

Other funds holding RMTI

UBS's RMTI Position: Q3 2014 in Review

UBS increased its Rockwell Medical (RMTI) stake by 1.8% in Q3 2014, buying an estimated $9.04K and bringing the position to 458 shares worth $461K. The position accounts for ﹤0.01% of the portfolio, ranked #4360.

UBS first reported a position in RMTI in Q2 2013 and has held it in 6 quarters since. The position peaked at $923K in Q1 2014. 82 funds tracked by Wall St. Rank hold RMTI as of Q3 2014.

  • UBS held 458 shares of Rockwell Medical worth $461K as of Q3 2014.
  • UBS bought 8 Rockwell Medical shares in Q3 2014, an estimated $9.04K.
  • Rockwell Medical made up ﹤0.01% of UBS's portfolio in Q3 2014, its #4360 holding.
  • UBS first reported a position in Rockwell Medical in Q2 2013 and has held it in 6 quarters since.
  • UBS's Rockwell Medical position peaked at $923K in Q1 2014.
  • 82 funds tracked by Wall St. Rank held Rockwell Medical as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.